rs45502793
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000335.5(SCN5A):c.*2135C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.043 ( 0 hom., cov: 0)
Failed GnomAD Quality Control
Consequence
SCN5A
NM_000335.5 3_prime_UTR
NM_000335.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.27
Publications
0 publications found
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]
SCN5A Gene-Disease associations (from GenCC):
- Brugada syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Brugada syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp, G2P, Ambry Genetics
- cardiac rhythm diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1EInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- familial long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- progressive familial heart block, type 1AInheritance: AD, SD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics
- sick sinus syndrome 1Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- atrial standstillInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial sick sinus syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- paroxysmal familial ventricular fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- progressive familial heart blockInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- congenital heart diseaseInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- short QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.052 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000335.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN5A | MANE Plus Clinical | c.*2135C>A | 3_prime_UTR | Exon 28 of 28 | NP_001092874.1 | H9KVD2 | |||
| SCN5A | MANE Select | c.*2135C>A | 3_prime_UTR | Exon 28 of 28 | NP_000326.2 | ||||
| SCN5A | c.*2135C>A | 3_prime_UTR | Exon 28 of 28 | NP_932173.1 | Q14524-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN5A | TSL:5 MANE Plus Clinical | c.*2135C>A | 3_prime_UTR | Exon 28 of 28 | ENSP00000410257.1 | H9KVD2 | |||
| SCN5A | TSL:1 MANE Select | c.*2135C>A | 3_prime_UTR | Exon 28 of 28 | ENSP00000398266.2 | Q14524-2 | |||
| SCN5A | TSL:1 | c.*2135C>A | 3_prime_UTR | Exon 28 of 28 | ENSP00000328968.4 | Q14524-1 |
Frequencies
GnomAD3 genomes AF: 0.0427 AC: 43AN: 1006Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
43
AN:
1006
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0AC: 0AN: 0Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.0427 AC: 43AN: 1006Hom.: 0 Cov.: 0 AF XY: 0.0478 AC XY: 24AN XY: 502 show subpopulations
GnomAD4 genome
AF:
AC:
43
AN:
1006
Hom.:
Cov.:
0
AF XY:
AC XY:
24
AN XY:
502
show subpopulations
African (AFR)
AF:
AC:
1
AN:
204
American (AMR)
AF:
AC:
4
AN:
94
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
20
East Asian (EAS)
AF:
AC:
0
AN:
14
South Asian (SAS)
AF:
AC:
0
AN:
40
European-Finnish (FIN)
AF:
AC:
1
AN:
104
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
36
AN:
514
Other (OTH)
AF:
AC:
0
AN:
10
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
Brugada syndrome 1 (1)
-
1
-
Congenital long QT syndrome (1)
-
1
-
Dilated cardiomyopathy 1E (1)
-
1
-
Long QT syndrome 3 (1)
-
1
-
Progressive familial heart block, type 1A (1)
-
1
-
Sick sinus syndrome 1 (1)
-
1
-
Ventricular fibrillation, paroxysmal familial, type 1 (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.